
|Articles|February 1, 2004
Complementary fillers seen as future of facial rejuvenation
New York - Comparing the pros and cons of facial rejuvenation techniques such as dermal fillers, Botox, and nonablative lasers is like comparing the pros and cons of peanut butter and jelly. They are completely different products that aren't nearly as effective alone as they are together. That's what oculoplastic surgeons Stephen Bosniak, M.D., New York, and Marian Zilkha, M.D., Brazil, found in their study of FDA-approved Restylane and Perlane (pending approval).
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
FDA Accepts Addition of Bemotrizinol as First New Sunscreen Ingredient in 20 Years
2
Moving Past Dermal Filler Trends to Focus on Healthy Skin Aging
3
Once-Daily Zasocitinib Rivals Injectable Biologics for Skin Clearance, Phase 3 Data Show
4
Filling the HS Treatment Gap: Ruxolitinib Targets Early-Stage Disease
5














